Press Releases

FLEMINGTON, N.J., Jan. 14, 2020 /PRNewswire/ -- EmphyCorp Inc. www.EmphyCorp.com, a Private Corporation, was proud to announce on August 12, 2019,  the c

NASHVILLE, Tenn., Jan. 14, 2020 /PRNewswire/ -- Just six months after raising $27 million in capital, IVX Health – a national provider of outpatient infusion

NEW YORK, Jan. 14, 2020 /PRNewswire/ -- Pause Well-Aging founder Rochelle Weitzner has been named a finalist in The Fashion Group International's (FGI) 23rd annual Rising Stars

PALMDALE, Calif., Jan. 14, 2020 /PRNewswire/ -- SHE Beverage Company, Inc., (the "Company") has filed its S-1 Offering Memorandum  with the SEC. The Company has also filed the requisite preliminary application for a ticker symbol with NASDAQ and anticipates trading on the NASDAQ Capital Markets with the ticker symbol of SHEB as issued by NASDAQ.  With

SAN DIEGO, Jan. 14, 2020 /PRNewswire/ -- My Green Lab is pleased to announce a collaboration with AstraZeneca to implement a global-scale green labs program across their research sites as part of their commitment to sustainability, including protecting the environment.

MINNEAPOLIS, Jan. 14, 2020 /PRNewswire/ -- Anytime Fitness, the world's largest and fastest-growing fitness club chain, is gearing up for its feature episode on CBS' award-winning series UN

IRVINE, Calif., Jan. 14, 2020 /PRNewswire/ -- For a second consecutive year, Xponential Fitness, the largest curator of boutique fitness brands in the world, lands three brands on

ATLANTA, Jan. 14, 2020 /PRNewswire/ -- Individuals and families in Greater Atlanta can now experience health care that is simple, convenient and affordable with the debut of HealthHUB, CVS Health's new store design in 16 CVS Pharmacy locations across the community. During a ribbon-cutting event at the company's HealthHUB location at 687 J

BOULDER, Colo., Jan. 14, 2020 /PRNewswire/ -- ArcherDX, Inc., today announced it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Personalized Cancer Monitoring (PCM) technology, a bespoke, minimally-invasive and highly-sensitive product intended for early-stage cancer treatment monitoring and recurrence surveillance.

BOULDER, Colo., Jan. 14, 2020 /PRNewswire/ -- MBio Diagnostics today announced two contracts with SRI International to develop tests related to homeland security on the MBio Diagnostics platform technology. MBio is a subcontractor on SRI programs sponsored by the US Biomedical Advanced Research and Development Authority (BARDA).